"We have a plan for antimicrobial resistance. We have set up a surveillance system, also connected to Covid, which talks about case histories, monitoring, sequencing of epidemiological situations and also the environmental level, for risk management. And this plan is a great opportunity to translate, once the pandemic is over, also towards antimicrobial resistance. And there is also the issue of risk management, we are evaluating the effectiveness of the measures adopted during the pandemic, and this is one of the scientific approaches necessary to understand if the choices we make have an impact. It is important to have professionals always ready to face the emergency ". The president of theIss Silvio Brusaferro speaking at an event organized by The European House - Ambrosetti with the contribution of Pfizer and bioMérieux, entitled "Planetary and Amr. Towards a new strategy to face global health challenges".
"We need to open a new season of investments for the National Health Service. And try to have a new vision, the One Health strategy, the one that brings together humans, the environment and animals is the right one. Antimicrobial resistance is today's theme, We have to invest in research. We have to work together, with synergies between public and private. Vaccines, the achievements of the last few months are the extraordinary result of synergies. We have to systematize the potential of research, together with the activities of the private sector with the public. To reverse the crisis of this time into an opportunity to relaunch: the conditions are there. We need a global pact as we are doing with the G20 for a global restart ".Health Minister Roberto Speranza said this in a message at an event organized by The European House - Ambrosetti with the contribution of Pfizer and bioMérieux, entitled "Planetary and Amr. Towards a new strategy to face global health challenges" .
